Erectile dysfunction - A cardiovascular disease?

Sexual and Relationship Therapy

Volumn 18, Issue 4, 2003, Pages 493-508

  Solomon, Hemant ^a   Jackson, Graham ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; SIMVASTATIN; THIAZIDE DIURETIC AGENT;

ATHEROSCLEROSIS; AWARENESS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG HYPERSENSITIVITY; ENDOTHELIUM LESION; ERECTILE DYSFUNCTION; HEALTH CARE PERSONNEL; HUMAN; HYPERTENSION; IMPOTENCE; MALE SEXUAL DYSFUNCTION; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SAFETY; SCREENING; UNITED KINGDOM; VASCULAR DISEASE;

EID: 0242694857     PISSN: 14681994     EISSN: None     Source Type: Journal    
DOI: 10.1080/14681990310001609822     Document Type: Review

References (45)

1. Ayta, I.A., McKinlay, J.B. & Krane, R. J. (1999). The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. British Journal of Urology International, 84, 50-56.
2. Azadzoi, K.M. & Saenz de Tejada, I. (1991). Hypercholesterolemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. Journal of Urology, 146, 238-240.
3. Behr-Roussel, D., Bernabe, J., Compagnie, S., Rupin, A., Verbeuren, T.J., Alexander, L. & Giuliano, F. (2002a) Distinct mechanisms implicated in atherosclerosis-induced erectile dysfunction in rabbits. Atherosclerosis, 162, 355-362.
4. Behr-Roussel, D., Chamiot-Clerc, P., Bernabe, J., Mevel, K., Alexander, L., Safar, M.E. & Giuliano, F. (2002b). Erectile dysfunction in spontaneously hypertensive rats: Pathophysiological mechanisms. American Journal of Physiology Regular Integrated Comprehensive Physiology, 284, 682-688.
5. Billups, K.F.S. (2000). Assessment of Fasting Lipid Panels and Doppler Ultrasound Testing in Men Presenting with Erectile Dysfunction and No Other Problems. Urology Association, Atlanta, USA.
6. Bortolotti, A., Parazzini, F., Colli, E. & Landoni, M. (1997). The epidemiology of erectile dysfunction and its risk factors. International Journal of Andrology, 20, 323-334.
7. Boyd, I.W. (1996). Comment: HMG-CoA reductase inhibitor-induced impotence. Annals of Pharmacotherapy, 30, 1199.
8. Brock, G. & Lue, T.F. (1993). Drug induced male sexual dysfunction. An update. Drug Safety, 8, 414-426.
9. Cheitlin, M.D., Hutter, A.M., Jr., Brindis, R.G., Ganz, P., Kaul, S., Russell, R.O., Jr. & Zusman, R.M. (1999). Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee. Circulation, 99, 168-177.
10. Chew, K.K., Earle, C.M., Stuckey, B.G., Jamrozik, K. & Keogh, E.J. (2000a). Erectile dysfunction in general medicine practice: Prevalence and clinical correlates. International Journal of Impotence Research, 12, 41-45.
11. Chew, K.K., Stuckey, B.G. & Thompson, P.L. (2000b). Erectile dysfunction, sildenafil and cardiovascular risk. Medical Journal of Australia, 172, 279-283.
12. De Angelis, L., Marfella, M.A., Siniscalchi, M., Marino, L., Nappo, F., Giugliano, F., De Lucia, D. & Giugliano, D. (2001). Erectile and endothelial dysfunction in Type II diabetes: A possible link. Diabetologia, 44, 1155-1160.
13. DeBusk, R., Drory, Y., Goldstein, I., Jackson, G., Kaul, S., Kimmel, S.E., Kostis, J.B., Kloner, R.A., Lakin, M., Meston, C.M., Mittleman, M., Muller, J.E., Padma-Nathan, H., Rosen, R.C., Stein, R.A. & Zusman, R. (2000). Management of sexual dysfunction in patients with cardiovascular disease: Recommendations of The Princeton Consensus Panel. American Journal of Cardiology, 86, 175-181.
14. Feldman, H.A., Goldstein, I., Hatzichristou, D.G., Krane, R.J. & McKinlay, J.B. (1994a). Construction of a surrogate variable for impotence in the Massachusetts Male Aging Study. Journal of Clinical Epidemiology, 47, 457-467.
15. Feldman, H.A., Goldstein, I., Hatzichristou, D.G., Krane, R.J. & McKinlay, J.B. (1994b). Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. Journal of Urology, 151, 54-61.
16. Frasure-Smith, N., Lesperance, F. & Talajic, M. (1993). Depression following myocardial infarction. Impact on 6-month survival. JAMA, 270, 1819-1825.
17. Gensini, G.G. (1983). A more meaningful scoring system for determining the severity of coronary heart disease. American Journal of Cardiology, 51, 606.
18. Goldstein, I. (2000). The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. American Journal of Cardiology, 86, 41F-45F.
19. Greenstein, A., Chen, J., Miller, H., Matzkin, H., Villa, Y. & Braf, Z. (1997). Does severity of ischemic coronary disease correlate with erectile function? International Journal of Impotence Research, 9, 123-126.
20. Grimm, R.H. Jr., Grandits, G.A., Prineas, R.J., McDonald, R.H., Lewis, C.E., Flack, J.M., Yunis, C., Svendsen, K., Liebson, P.R. & Elmer, P.J. (1997). Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension, 29, 8-14.
21. Jackson, G. (2000). Sexual intercourse and stable angina pectoris. American Journal of Cardiology, 86, 35F-37F.
22. Jackson, G. (1997). Simvastatin and impotence. British Medical Journal, 315, 31.
23. Jackson, G., Betteridge, J., Dean, J., Hall, R., Holdright, D., Holmes, S., Kirby, M., Riley, A. & Sever, P. (1999). A systematic approach to erectile dysfunction in the cardiovascular patient: A consensus statement. International Journal of Clinical Practice, 53, 445-451.
24. Jackson, G.B.J., Dean, J., Eardley, I., Hall, R., Holdright, D., Holmes, S., Kirby, M., Riley, A. & Sever, P. (2002). A systematic approach to erectile dysfunction in the cardiovascular patient: A consensus statement - Update 2002. International Journal of Clinical Practice, 56, 1-9.
25. Jensen, J., Lendorf, A., Stimpel, H., Frost, J., Ibsen, H. & Rosenkilde, P. (1999). The prevalence and etiology of impotence in 101 male hypertensive outpatients. American Journal of Hypertension, 12, 271-275.
26. Kawanishi, Y., Lee, K.S., Kimura, K., Koizumi, T., Nakatsuji H., Kojima, K., Yamamoto, A., Numata, A. & Sogou, T. (2001). Screening of ischemic heart disease with cavernous artery blood flow in erectile dysfunctional patients. International Journal of Impotence Research, 13, 100-103.
27. Kim, S.W., Paick, J., Park, D.W., Chae, I. & Oh, B. (2001). Potential predictors of asymptomatic ischemic heart disease in patients with vasculogenic erectile dysfunction. Urology, 58, 441-445.
28. Kloner, R.A. (2000). Cardiovascular risk and sildenafil. American Journal of Cardiology, 86, 57F-61F.
29. Lee, E.S., Kor, D.J., Kuskowski, M.A. & Santilli, S.M. (2000). Incidence of erectile dysfunction after open abdominal aortic aneurysm repair. Annals of Vascular Surgery, 14, 13-19.
30. Llisterri, J.L., Lozano Vidal, J.V., Aznar Vicente, J., Argaya Roca, M., Pol Bravo, C., Sanchez Zamorano, M.A. & Ferrario, C.M. (2001). Sexual dysfunction in hypertensive patients treated with losartan. American Journal of Medical Science, 321, 336-341.
31. Lue, T.F. (2000). Erectile dysfunction. New England Journal of Medicine, 342, 1802-1813.
32. Malzberg, B. (1937). Mortality among patients with involution melancholia. American Journal of Psychiatry, 93, 1231-1238.
33. Moreira, E.D. Jr., Abdo, C.H., Torres, E.B., Lobo, C.F. & Fittipaldi, J.A. (2001). Prevalence and correlates of erectile dysfunction: Results of the Brazilian study of sexual behavior. Urology, 58, 583-588.
34. Muller, J.E. (1999). Sexual activity as a trigger for cardiovascular events: What is the risk? American Journal of Cardiology, 84, 2N-5N.
35. National Institutes of Health Consensus Conference. (1993). Impotence. NIH Consensus Development Panel on Impotence. Jama, 270, 83-90.
36. Pritzker, M. (2000). The Penile Stress Test: A window to the hearts of man? Circulation, 100, P3751.
37. Saenz De Tejada, I., Goldstein, I., Azadzoi, K., Krane, R.J. & Cohen, R.A. (1989). Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle for diabetic men with impotence. New England Journal of Medicine, 320, 1025-1030.
38. Sairam, K., Kulinskaya, E., Boustead, G.B., Hanbury, D.C. & McNicholas, T.A. (2001). Prevalence of undiagnosed diabetes mellitus in male erectile dysfunction. British Journal of Urology International, 88, 68-71.
39. Solomon, H., Man, J., Wierzbicki, A.S., O'Brien, T. & Jackson, G. (2003a). Erectile dysfunction: Cardiovascular risk and the role of the cardiologist. International Journal of Clinical Practice, 57, 96-99.
40. Solomon, H., Man, J.W., Wierzbicki, A.S. & Jackson, G. (2003b). Relation of erectile dysfunction to angiographic coronary artery disease. American Journal of Cardiology, 91, 230-231.
41. Solomon, H.M.J., Martin, E. amp; Jackson, G. (2002). Erectile dysfunction is a marker of asymptomatic peripheral vascular disease. International Journal of Impotence Research, 14, S20.
42. Sullivan, M.E., Thompson, C.S., Dashwood, M.R., Khan, M.A., Jeremy, J.Y., Morgan, R.J. & Mikhailidis, D.P. (1999). Nitric oxide and penile erection: Is erectile dysfunction another manifestation of vascular disease? Cardiovascular Research, 43, 658-665.
43. Virag, R., Bouilly, P. & Frydman, D. (1985). Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet, 1, 181-184.
44. Wei, M., Macera, C.A., Davis, D.R., Hornung, C.A., Nankin, H.R. & Blair, S.N. (1994). Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. American Journal of Epidemiology, 140, 930-937.
45. Willke, R.J., Glick, H.A., McCarron, T.J., Erder, M.H., Althof, S.E. & Linet, O.I. (1997). Quality of life effects of alprostadil therapy for erectile dysfunction. Journal of Urology, 157, 2124-2128.